Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

Viewing Page 3 of 4 | Showing Results 11 - 15 of 18

Long-term, Prospective,Multinational, Parallel-cohort Study Monitoring Safety in Patients With MS Newly Started With Fingolimod Once Daily or Treated With Another Approved Disease-modifying Therapy

Inclusion Criteria:Patients that as part of their routine clinical care and according to the locally approved label, are either;Starting fingolimod...

Hui-Juan Zhang, M.D.
  • Kadlec Neuroscience Center
  • Kadlec Research

Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab.

Inclusion Criteria:Able to understand the purpose and risk of the study and provide signed informed consent document.Must have received 12 or more...

Hui-Juan Zhang, M.D.
  • Kadlec Neuroscience Center
  • Kadlec Research

A Randomized, Double-Blind, Phase 3 Comparison of Platinum-Based Therapy with TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (3000-03-005/ENGOT-OV44)

Inclusion Criteria:•Patients with a histologically confirmed diagnosis of high-grade nonmucinous epithelial ovarian cancer (serous, endometrial,...

Ying Zhuo, M.D.
  • Kadlec Clinic Hematology and Oncology
  • Kadlec Research

RSH Connect MDS AML-Connect MDS and AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

Newly diagnosed, primary or secondary MDS or AML, or ICUS AML patient must be at least 55 years of age;MDS/ICUS patient must be at least 18 years...

Rangaswamy Chintapatla, M.D.
  • Kadlec Clinic Hematology and Oncology
  • Kadlec Research

THE VALUE OF ORENICA IN RAPIDLY PROGRESSING RHEUMATOID ARTHRITIS: A CHART REVIEW STUDY

Kalpita Hatti, M.D.
  • Kadlec Clinic Rheumatology
  • Kadlec Research
Viewing Page 3 of 4 | Showing Results 11 - 15 of 18